Long-term Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata: 104-Week Results from BRAVE-AA1 and BRAVE-AA2
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY(2024)
关键词
Alopecia Areata
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要